Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Sign Up to like & getrecommendations! Published in 2025 at "Nature Microbiology"
DOI: 10.1038/s41564-025-01930-y
Abstract: The gut microbiome modulates immunotherapy treatment responses, and this may explain why immune checkpoint inhibitors, such as anti-PD-1, are only effective in some patients. Previous studies correlated lipopolysaccharide (LPS)-producing gut microbes with poorer prognosis; however,… read more here.
Keywords: hexa acylated; acylated lps; microbiota derived; immunotherapy responses ... See more keywords